Company news

Rakovina Therapeutics Inc news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Rakovina Therapeutics Announces 2025 Q1 Financial Results and Provides Corporate Update

June 2, 2025

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations

May 28, 2025

Rakovina Therapeutics Announces Strategic Private Placement, Convertible Debt Financing, and Share Consolidation to Accelerate US-Focused Growth and AI-Powered Oncology Innovation

May 15, 2025

Rakovina Therapeutics Announces Appointment of Dr. David Kideckel as Chief Financial Officer

May 5, 2025

Rakovina Therapeutics Inc. Announces 2024 Financial Results and Provides Corporate Update

April 30, 2025

Rakovina Strengthens Board with Appointments of Yevgeniy Meshcherekov and David Kideckel

April 29, 2025

Rakovina Therapeutics Showcases Preclinical Results of Novel AI-Discovered Cancer Therapies at AACR 2025

April 29, 2025

Rakovina Therapeutics Congratulates Scientific Advisor Dr. Artem Cherkasov on Global Recognition for Breakthrough AI Innovation in Drug Discovery

April 22, 2025

Rakovina Therapeutics Unveils Preclinical Data at the AACR - World's Premier Cancer Research Forum

March 25, 2025

Next-Gen Cancer Treatment: Rakovina's AI-Driven ATR Inhibitors Enter Preclinical Testing

March 12, 2025

Rakovina Therapeutics and Variational AI Strengthen Partnership

February 26, 2025

Accelerating New Molecule Discovery: Rakovina Therapeutics AI Integration

April 2, 2024

Rakovina Therapeutics continues to make progress as company provides corporate update

September 13, 2023

Rakovina Therapeutics shares new kt-3000 data at American Association of Cancer Research event

April 24, 2023

Rakovina Therapeutics receives government grant to accelerate novel cancer therapy program

March 24, 2023

Rakovina Therapeutics: Transform & Extend the Lives of Patients with Cancer, CEO Clip Video

May 27, 2022

Life Sciences Companies Investor Presentations Now Available for On-Demand Viewing

December 20, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Partnership with St. Baldrick's Foundation to Research and Develop New Treatments for Childhood Bone Cancer - Video Available on Investmentpitch.com

November 17, 2021

InvestmentPitch Media Video Discusses Rakovina Therapeutics' Receipt of Notice of Allowance for New U.S. Patent Covering kt-2000 Series PARP Inhibitors - Video Available on Investmentpitch.com

October 8, 2021

Rakovina Therapeutics to Present at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

August 17, 2021

Red Thread Ventures' portfolio company Rakovina Therapeutics'

August 11, 2021

Rakovina Therapeutics Announces Results from Annual General Meeting

June 29, 2021

Rakovina Therapeutics to Present at at The Emerging Growth Conference on June 23, 2021

June 17, 2021

Rakovina Therapeutics Inc. Announces First Quarter 2021 Financial Results and Provides Corporate Update

May 27, 2021

Rakovina Therapeutics Inc. Announces Inaugural Scientific Advisory Board

April 29, 2021

Rakovina Therapeutics Inc. Receives European and Canadian Patents on kt-2000 series PARP-inhibitors

April 8, 2021

Rakovina Therapeutics Inc. Appoints Biotechnology Industry Veteran Julie M. Cherrington, PhD to Board of Directors

April 5, 2021

InvestmentPitch Media Video Discusses Newly Listed Rakovina Therapeutics, a Developer of New Cancer Treatments Targeting Critical DNA Damage Response Mutations - Video Available on Investmentpitch.com

April 5, 2021

Rakovina Therapeutics Inc. Commences Trading on TSX Venture Exchange Under Ticker Symbol "RKV"

April 1, 2021

← Newer news releases

Decks

The 5 newest of 15 decks. Every deck is listed under its year.